QGEN Competitors & Alternatives
Compare Qiagen NV with similar stocks in the same industry
Diagnostics & Research
QGEN
Main Stock$40.10
Tradestie Score
60
Market Cap
$10.04B
P/E Ratio
20.0
Revenue Growth
0.0%
Analyst Upside
+9.6%
Top Competitors
37 stocks in Diagnostics & Research| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXAS
Exact Sciences Corp
|
$104.91
|
$10.68B | - | 65 | Compare |
|
RVTY
Revvity, Inc.
|
$113.76
|
$10.65B | 54.3 | 61 | Compare |
|
TECH
Bio-Techne Corp.
|
$70.83
|
$9.33B | 101.4 | 53 | Compare |
|
CRL
Charles River Laboratories International, Inc.
|
$230.69
|
$8.39B | - | 60 | Compare |
|
BIO
Bio-Rad Laboratories, Inc.Class A
|
$296.86
|
$8.06B | 49.4 | 60 | Compare |
|
GH
Guardant Health, Inc. Common Stock
|
$167.98
|
$7.81B | - | 61 | Compare |
|
RDNT
RadNet, Inc. Common Stock
|
$68.75
|
$6.00B | - | 59 | Compare |
|
BLLN
BLLN
|
$120.35
|
$5.55B | 223.3 | 62 | Compare |
|
SHC
Sotera Health Company Common Stock
|
$17.93
|
$4.60B | 43.3 | 57 | Compare |
|
WGS
GeneDx Holdings Corp. Class A Common Stock
|
$67.51
|
$3.26B | - | 59 | Compare |
More QGEN Analysis
Data updated: Jul 03, 2026 | Industry: Diagnostics & Research (SIC 2836)
37 stocks in this industry